Effect of LASER Photobiomodulation Therapy on Chronic Pain and Opioid Weaning

Exclusion Criteria

• •Not capable of understanding or completing study questionnaires.
• •Lacking capacity to provide fully informed consent.
• •Substance use disorder not in remission.
• •Considering surgery or other invasive procedures that would take place during the study.
• •Used isotretinoin (Accutane) within 6 months prior to study enrollment
• •Cancer not in remission.
• •Need of ongoing Transcutaneous Electrical Nerve Stimulation (TENS) therapy, massage therapy, chiropractic care or other treatments intended to remediate pain other than treatment in the Sharp Pain Program.
• •A female who is pregnant or lactating, or of childbearing potential unless a medically acceptable method of birth control is in use.
• •Any use of light-activated drugs (photodynamic therapy) or heat sensitive medications within 30 days of first treatment.
• •Used an investigational drug/device therapy or participated in any clinical investigation relating to pain within 4 weeks prior to study enrollment.
• •A psychiatric or psychological condition that would place undo stress on the subject, prevent full participation or compromise data collection.
• •The subject is otherwise determined, based on the opinion of the Investigator, to be an unsuitable candidate for enrollment in this study